GLENMARK PHARMACEUTICALS LTD. (GLENMARK) share price
GLENMARK PHARMACEUTICALS LTD. (GLENMARK) is listed in the Pharmaceuticals industry (Healthcare sector). It trades at ₹2,210.2 (-0.74% on the day), with a market capitalisation of ₹62,342.92 crore. Its PE ratio is 34.71 on EPS of ₹63.68. The 52-week range is ₹1,792.6 – ₹2,537.6, and the stock is 12.9% below its 52-week high.
| Share price | ₹2,210.2 |
|---|---|
| Day change | -0.74% |
| Market cap | ₹62,342.92 Cr |
| PE ratio | 34.71 |
| EPS | ₹63.68 |
| 52-week high | ₹2,537.6 |
| 52-week low | ₹1,792.6 |
| Face value | 1 |
Peers in Pharmaceuticals
- SUN PHARMACEUTICAL INDUSTRIES LTD. share price – ₹1,743
- DIVI'S LABORATORIES LTD. share price – ₹9,087
- TORRENT PHARMACEUTICALS LTD. share price – ₹4,558.7
- Laurus Labs Ltd share price – ₹2,069
- Zydus Lifesciences Ltd share price – ₹1,113.9
- CIPLA LTD. share price – ₹1,324.1
- AUROBINDO PHARMA LTD. share price – ₹1,621.4
- Mankind Pharma Ltd share price – ₹2,253.2